After a prolonged downturn lasting nearly four years, the biotechnology industry is showing clear signs of recovery. Taking ...
Dodge Construction Network, in partnership with Procore Technologies, Inc. , the leading global provider of construction management software, today announced the findings of a new study that measures ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
SUFFERN - Biotech powerhouse Regeneron has confirmed it will sell its Suffern site, two years after purchasing the former ...
Strategic focus shifted from U.S.-centric growth to global expansion, with launches in Germany, France, and Japan. Analysts’ questions in this quarter were more international and operationally focused ...
When Big Pharma ties its corporate social responsibility initiatives to patients' needs, too often it veers into theater.
Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO ) has just made one of the boldest ...
America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.
The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback